Filing Manager
Voss Capital, LP
Reporting Manager
Voss Capital, LP
Symbol
ACTU
Shares outstanding
23,165,208 shares
Disclosed Ownership
1,227,756 shares
Ownership
5.3%
Form type
SCHEDULE 13G
Filing time
17 Dec 2025, 12:25:51 UTC
Date of event
15 Dec 2025

Sponsored

Quoteable Key Fact

"Voss Capital, LP disclosed 5.3% ownership in ACTUATE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (ACTU) on 15 Dec 2025."

Quick Takeaways

  • Voss Capital, LP filed SCHEDULE 13G for ACTUATE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (ACTU).
  • Disclosed ownership: 5.3%.
  • Date of event: 15 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Dec 2025, 12:25.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Voss Capital, LP 5.3% 1,227,756 1,200,000 27,756 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Cocke Travis W. 5.3% 1,227,756 1,200,000 27,756 /s/ Travis W. Cocke Travis W. Cocke
Voss Advisors GP, LLC 1.1% 250,000 250,000 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Voss Value Master Fund, LP 0.9% 200,000 200,000 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Value-Oriented Special Situations Fund, LP 0.2% 50,000 50,000 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner